SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • December 22nd, 2020 • Quanta Inc • Medicinal chemicals & botanical products • Nevada
This Securities Exchange Agreement (this “Agreement”) is dated as of December 21, 2020, by and among the shareholders of Medolife Rx, Inc., representing fifty-one percent (51%) of the total outstanding shares, thereof (collectively the “Seller”), Medolife Rx, Inc., a Wyoming corporation (the “Company”), and Quanta, Inc., a Nevada corporation (the “Purchaser”).
